Company intelligence / Profile preview

ARC Dialysis

Miami, Florida, United States

Ownership: Private
Employees: ~69
Development stage: Other

Overview

ARC Dialysis is a leading independent dialysis provider offering acute, chronic, outpatient, and in-home therapies for patients with kidney failure and ESRD across multiple states, including Florida and Texas. The company operates multiple free-standing dialysis centers, partners with numerous hospitals/skilled nursing facilities, and is Joint Commission Accredited. Recently, ARC Dialysis entered a commercial agreement to implement DefenCath (taurolidine and heparin) as an infection prevention strategy in their hemodialysis population[1][5].

Therapeutic areas: Nephrology
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

CorMedix (commercial supply agreement for DefenCath[5])

Beyond the preview

Go deeper on ARC Dialysis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARC Dialysis.

Explore the full profile